Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Volitionrx (VNRX) Enterprise Value (2019 - 2025)

Volitionrx's Enterprise Value history spans 8 years, with the latest figure at -$2.5 million for Q4 2025.

  • For Q4 2025, Enterprise Value rose 44.82% year-over-year to -$2.5 million; the TTM value through Dec 2025 reached -$2.5 million, up 44.82%, while the annual FY2025 figure was -$2.5 million, 44.82% up from the prior year.
  • Enterprise Value reached -$2.5 million in Q4 2025 per VNRX's latest filing, down from -$1.5 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$1.5 million in Q3 2025 to a low of -$33.1 million in Q1 2021.
  • Average Enterprise Value over 5 years is -$13.3 million, with a median of -$11.5 million recorded in 2022.
  • Peak YoY movement for Enterprise Value: surged 92.84% in 2022, then tumbled 608.37% in 2023.
  • A 5-year view of Enterprise Value shows it stood at -$20.8 million in 2021, then skyrocketed by 45.11% to -$11.4 million in 2022, then tumbled by 89.51% to -$21.6 million in 2023, then skyrocketed by 79.37% to -$4.5 million in 2024, then skyrocketed by 44.82% to -$2.5 million in 2025.
  • Per Business Quant, the three most recent readings for VNRX's Enterprise Value are -$2.5 million (Q4 2025), -$1.5 million (Q3 2025), and -$3.5 million (Q2 2025).